Professor
Centre for Blood Research, University of British Columbia
Vancouver, British Columbia, Canada
Dr. Kizhakkedathu is a Professor and Tier 1 Canada Research Chair in the Department of Pathology and Laboratory Medicine, a Principal Investigator at the Centre for Blood Research (CBR) and an Associate Member with the Department of Chemistry, The School of Biomedical Engineering at the University of British Columbia (UBC). Dr. Kizhakkedathu is leading a cutting-edge translational research program to innovate materials and therapeutics that can treat and prevent immunothrombosis and infection, immunological rejection of organs and cells, and protection of tissues and organs in inflammatory conditions. Dr. Kizhakkedathu take an integrative, interdisciplinary approach combining an understanding of the pathophysiology of diseases and advanced polymer/material synthesis with well‐designed biological assays and animal models to discover therapeutics, and technologies for biomedical and clinical use.
Dr. Kizhakkedathu’s research has been published in both fundamental science and clinical journals including the top journals in biomaterials, biotechnology, materials, translation medicine and hematology (~215): Science Translational Medicine, Nature Materials, Nature Biotechnology, Nature Biomedical Engineering, Nature Communications, Blood, Journal of the American Chemical Society, Biomaterials, ACS Nano, ACS Central Science among many others, and several patents (~30) which form the foundation of a few companies.
Dr. Kizhakkedathu has received numerous other awards and recognitions including the Canada Research Chair Tier 1 in Immunomodulating Materials and Immunotherapy, Distinguished Achievement Award in Excellence in Basic Science Research from Faculty of Medicine in 2022, named as a Fellow Biomaterials Science and Engineering (FBSE) (2020) by the World Biomaterials Congress, the UBC Killam Research Prize in 2017, and the Department of Pathology and Laboratory Medicine Excellence in Research and Discovery Award in 2011. He was also recognized as a Michael Smith Foundation for Health Research Scholar (MSFHR) in 2011 and was honoured with the Canadian Institutes of Health Research (CIHR) New Investigator Award in 2005.
PB0416 - Platelet polyphosphate activates NFκB signaling to induce myofibroblast differentiation
Sunday, June 25, 2023
18:30 – 19:30 ET
Monday, June 26, 2023
18:30 – 19:30 ET
PB0906 - Modified Platelet Storage Devices to Improve Quality During Storagee
Monday, June 26, 2023
18:30 – 19:30 ET
OC 55.5 - Safe Nucleic acid Inhibitors That Show Protection Against Immunothrombosis in Sepsis
Tuesday, June 27, 2023
11:45 – 12:00 ET
Tuesday, June 27, 2023
15:45 – 16:00 ET